FDA AI Guidance Requires Sponsors to Validate Clinical Trial Algorithms
Published . Updated .
FDA AI Guidance Requires Sponsors to Validate Clinical Trial Algorithms The Clinical Trial Vanguard
Directly affected
- No company is named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
FDA AI Guidance Requires Sponsors to Validate Clinical Trial Algorithms The Clinical Trial Vanguard
Source: The Clinical Trial Vanguard
This story
12 out of 100
“FDA AI Guidance Requires Sponsors to Validate Clinical Trial Algorithms” scores 12 out of 100. The score uses 1 sources.